Earnings Call · Q4 FY2023·2024-03-21

Q4 23EPS -55.56%·Rev n/aQ3 23EPS -18.18%·Rev n/aQ2 23EPS -22.22%·Rev n/aQ1 23EPS +28.57%·Rev n/a⚠ consensus missing

Apyx Medical Corp APYX

Charles D. Goodwin — Chief Executive Officer

Matt Hill — Chief Financial Officer

−3.1%1d on move date−4.5% vs SPY3d−6.9%5d−14.6%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more APYX calls or request research access.

More APYX calls Browse calls Request research access